Fortitude Family Office’s ImageneBio Inc IMA Stock Holding History

Fortitude Family Office’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400	Closed	-$2.76K	–	1982
2025 Q4	$2.76K	Buy	+400	New	+$2.97K	﹤0.01%	1046

Other funds holding IMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fortitude Family Office's IMA Position: Q1 2026 in Review

Fortitude Family Office sold out of ImageneBio Inc (IMA) in Q1 2026, closing a stake of 400 shares — an estimated $2.76K sold.

Fortitude Family Office first reported a position in IMA in Q4 2025 and held it in 1 quarter. The position peaked at $2.76K in Q4 2025. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

Fortitude Family Office reported no remaining ImageneBio Inc position as of Q1 2026 after selling out during the quarter.
Fortitude Family Office sold 400 ImageneBio Inc shares in Q1 2026, an estimated $2.76K.
Fortitude Family Office first reported a position in ImageneBio Inc in Q4 2025 and held it in 1 quarter.
Fortitude Family Office's ImageneBio Inc position peaked at $2.76K in Q4 2025.
39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.